β-blockers |
Bisoprolol (substrate/inhibitor), Propranolol
(substrate/inhibitor) |
Calcium channel blockers |
Diltiazem (substrate/inhibitor), Verapamil
(substrate/inhibitor) |
Antiarrhythmic agents |
Amiodarone (inhibitor), Dronedarone (inhibitor),
Propafenone (inhibitor) |
Oral anticoagulants |
Apixaban (substrate), Dabigatran (substrate),
Edoxaban (substrate), Rivaroxaban (substrate), Warfarin
(substrate/inhibitor) |
Others |
Digoxin (substrate) |
COVID-19 drugs |
Azithromycin (substrate/inhibitor) |
Medications that are CYP3A4 substrates |
Medications that are CYP3A4
substrates |
Calcium channel blockers |
Diltiazem, Verapamil |
Antiarrhythmic agents |
Amiodarone |
Oral anticoagulants |
Apixaban, Rivaroxaban |
COVID-19 drugs |
Hydroxychloroquine, Azithromycin |